Abstract

The advantages of effective postoperative pain management include patient comfort and therefore satisfaction; earlier mobilization, fewer pulmonary/cardiac complications, reduced risk of deep vein thrombosis, speedy recovery with less likelihood of developing neuropathic pain and reduced expenses. Thirty cases in each group were recruited for the study and were randomized to receive Ropivacaine alone or Ropivacaine with Dexmedetomidine. A pilot study was conducted to arrive at the actual mean differences, and the outcome parameters being studied with the visual analogue scale (VAS), Modified Bromage score and mean time for first analgesic requirement. Randomization was done based on computer generated randomization method. There was no statistically significant difference in mean VAS between both the groups at baseline (p=0.784), 5 minutes (p=0.897), 10 minutes (p=0.936), 15 minutes (p=0.196), 30 minutes (p=0.050), 45 minutes (p=0.084), 60 minutes (p=0.084), 75 minutes (p=0.062), and 105 minutes (p=0.141). There was a statistically significant difference at 90 minutes (p=0.044) and from 120 minutes onwards and thereafter (p<0.05) during follow up. Dexmedetomidine group had lower VAS compared to the control group.

Description